Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Senate grills Novo Nordisk CEO on weight loss drug pricing
Bernie Sanders grills Novo Nordisk CEO on price of Ozempic, other weight-loss drugs
Sen. Bernie Sanders grilled Novo Nordisk's CEO Lars Jorgensen over the cost of the company's weight loss and diabetes medications, Ozempic and Wegovy.
Novo Nordisk CEO faces US Congress scrutiny over weight-loss drug pricing
U.S. Senator Bernie Sanders is set to question Novo Nordisk CEO Lars Jorgensen on Tuesday over the drugmaker's prices for its popular weight-loss and diabetes medicines that can cost Americans more than $1,
Lawmakers press Novo Nordisk CEO over weight-loss drug prices
The Senate Committee on Health, Education, Labor and Pensions held a hearing on Tuesday, to discuss Novo Nordisk lowering prices for weight-loss drugs.
3d
Novo CEO to blame drug middlemen
The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...
2d
PBMs willing to expand coverage if Novo Nordisk cuts prices: report
Leading pharmacy benefit managers are reportedly willing to expand coverage for Novo Nordisk’s (NVO) popular diabetes and ...
3d
Novo says Ozempic to be eligible for US price negotiations in less than a year
Novo Nordisk's blockbuster diabetes drug Ozempic will be eligible for U.S. government's price negotiations in less than a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Counselor accused of assault
Dropped from Vegas festival
Gets 18 years for racist plot
Stadiums to serve as shelters
Seeks dismissal of charges
Listeria outbreak death toll
On Secret Service failures
Chinese submarine sank
Kotb leaving 'Today'
Unveils economic plans
Disney layoffs
Military recruiting rebounds
To withdraw sickle cell drug
Targeted Black residents?
Rose announces retirement
Settles defamation lawsuit
Disbarred in DC
WI duplicate ballot flap
NC board removes 747K
‘Salt Typhoon’ cyberattack
ISR rejects ceasefire talks
Acquitted of 1966 murders
US suicides steady, high
On active shooter drills
$8B military aid for Ukraine
Capital goods orders up
RU hits Ukraine's power grid
Jan. 6 report delayed
Weekly jobless claims fall
US economy grew
Arrives in Luxembourg
NIH finds misconduct
Feedback